Item 5.07. Submission of Matters to a Vote of Security Holders.



On May 20, 2021, Harmony Biosciences Holdings, Inc. (the "Company") held its
2021 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual
Meeting, stockholders voted on the following two proposals, each of which is
described in detail in the Company's definitive proxy statement filed with the
Securities and Exchange Commission on April 9, 2021.

Proposal 1. The election of the three Class I directors listed below to serve until the Company's 2024 annual meeting of stockholders and until their successors are duly elected and qualified.





                                                                                        % Votes         Broker Non-
                                   Votes For        % Votes For         Withheld        Withheld           Votes
Jeffrey S. Aronin                   35,276,131              71.6 %      13,977,307           28.4 %          806,920
R. Mark Graf                        49,200,016              99.9 %          53,422            0.1 %          806,920
John C. Jacobs                      39,882,314              81.0 %       9,371,124           19.0 %          806,920

Based on the votes set forth above, each of the director nominees was duly elected.

Proposal 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.





                        Votes For    Votes Against   Abstain
                        50,059,172        700          486


Based on the votes set forth above, the appointment of Deloitte & Touche LLP as
the Company's independent registered public accounting firm for the fiscal year
ending December 31, 2021 was duly ratified.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses